ArticleBiotechnology and bioengineering2018

cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate.

Antu K Dey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.